Navigation Links
Nil in Medical News

Ahmedabad Pronounced Safe with Nil Bird Flu Cases

Gujarat Health Minister Ashok Bhatt has confirmed the absence of bird-flu cases in Gujarat. Preliminary investigation of a person suspected of bird-flu// also yielded negative results. Kadar Murghiwala, a poultry dealer in Jamalpur, took ill after 200 chickens under his care died. Suspecting a ...

Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009

... - Commitments and contingencies STOCKHOLDERS' EQUITY: Preferred stock - $.001 par value; authorized 5,000,000 shares; non-voting; nil shares outstanding - - Common stock - $.001 par value; authorized 325,000,000 s...

BELLUS Health reports results for first quarter of fiscal 2009

...res implemented by the Company to reduce its burn rate. Marketing and selling expenses amounted to $1,878,000 for the current quarter compared to nil for the same quarter the previous year and represent expenses incurred in relation to the commercialization of the Company's natural health brand, VIV...

BELLUS Health reports results for the fourth quarter of 2008

...ducts and in the medium- to long-term through development of a pipeline of pharmaceutical products. Revenue from collaboration agreement amounted to nil for the current quarter ($205,000 for the year), compared to $206,000 for the same period the previous year ($1,119,000 for the year). This revenue wa...

Aflac Incorporated Announces Fourth Quarter Results, Sees 2008 RBC Ratio Above 450%, Affirms 2009 Operating EPS Target

... earnings in the fourth quarter included realized investment losses of $262 million, or $.56 per diluted share, compared with a loss of $1 million, or nil per diluted share in the fourth quarter of 2007. Approximately $117 million of the after-tax investment losses in the fourth quarter related to the p...

Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2009

...0 Commitments and contingencies STOCKHOLDERS' EQUITY: Preferred stock-$.001 par value; authorized 5,000,000 shares; non-voting; nil shares outstanding - - Common stock-$.001 par value; authorized 325,000,000 shares; outstanding - ...

BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update

... Revenue from collaboration agreement amounted to nil for the current quarter ($205,000 for the nine-mon...Centocor. Reimbursable costs revenue amounted to nil for the current quarter ($69,000 for the nine-mont... current quarter. Reimbursable costs amounted to nil for the current quarter ($69,000 for the nine-mont...

PreMD Reports Second Quarter Results

..., 2007 (Q2 2007). Total product sales were $6,000 for Q2 2008 compared with $8,000 for Q2 2007. License revenue was $27,000 for Q2 2008, compared to nil for Q2 2007. Product sales reflect direct sales to customers. The license revenue in 2008 consisted of the upfront cash payment received in accordance...

MDS Reports Second Quarter 2008 Results

...justed EBITDA was a loss of $1 million compared to nil last year as unfavourable revenue mix, foreign exc...rnings per share from discontinued operations were nil compared to $5.77 which included $5.76 related to ...-- MDS Pharma Services had an operating income of nil for the quarter, compared to a loss of $98 million...

InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008

...t quarter of 2008 compared with an operating loss of $255,682 recorded during the first quarter 2007. The Company incurred a net profit of $41,730, or nil per basic and diluted share for the quarter ended March 31, 2008, compared with a net loss of $403,203 or ($0.04) per basic and diluted share reported...

More>>

Nil in Biological Technology

Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion

...56.8 million shares issued and outstanding) 55.5 55.2 Exchangeable shares: nil shares issued and outstanding (2007: 0.7 million) - 33.6 Treasury stock : 20.7 million shares (2007: 10....

Sinovac Reports Third Quarter 2008 Unaudited Financial Results

... third quarter of 2008, Sinovac sold 28,000 doses of Bilive(R), compared to nil doses in the prior year period. As mentioned previously, the year-over-yea...Company sold 234,000 doses of Bilive(R) during the 2008 period, compared to nil doses in the prior year period. As mentioned previously, the year- over-ye...

Shire's New Product Portfolio Delivers Strong Quarterly Performance

...d; and 556.8 million shares issued and outstanding) 55.5 55.2 Exchangeable shares: nil shares issued and outstanding (2007: 0.7 million) - 33.6 Treasury stock (21.0 million shares (2007: 10.3 ...

Helix BioPharma Corp. Announces Fiscal 2008 Results

...ompared to fiscal 2007 while research and development contract revenue were nil in fiscal 2008 and therefore lower than fiscal 2007. Overall expenses in ...ompared to fiscal 2007 while research and development contract revenue were nil in fiscal 2008 and therefore lower than fiscal 2007. Product revenue in f...

Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009

... 22,000 Commitments and contingencies STOCKHOLDERS' EQUITY: Preferred stock -- $.001 par value; authorized 5,000,000 shares; non-voting; nil shares outstanding - - Common stock -- $.001 par value; authorized 325,000,000 shares; outstanding -- 226...

InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008

... quarter of 2008 compared with an operating loss of $174,475 recorded during the second quarter 2007. The Company incurred a net profit of $17,652, or nil per basic share for the quarter ended June 30, 2008, compared with a net loss of $150,570 or ($0.01) per basic and diluted share reported for the quar...

Sinovac Reports Record Second Quarter 2008 Unaudited Financial Results

...ock -- -- Authorized 50,000,000 shares at par value of $0.001 each Issued and outstanding: nil Common stock 42,854 40,305 Authorized: 100,000,000 shares at par value of $0.001 each Issued a...

Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.

... 750 million shares authorized; and 553.2 million shares issued and outstanding) 55.5 55.2 Exchangeable shares: nil shares issued and outstanding (2007: 0.7 million) - 33.6 Treasury stock (19.6 million shares (380.5) ...

Oncolytics Biotech Inc. Announces 2008 Second Quarter Results

...------------------ Cash dividends declared(6) nil nil nil ...

Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008

...- 4,000 Commitments and contingencies STOCKHOLDERS' EQUITY: Preferred stock - $.001 par value; authorized 5,000,000 shares; non-voting; nil shares outstanding - - Common stock - $.001 par value; authorized 325,000,000 shares; outs...
Other Tags
(Date:7/13/2014)... Advanced boilers are preferred over conventional boilers ... fuels, produce high-capacity power, emit fewer pollutants, and ... and climate change concerns, many countries have implemented ... and pollutants coming from fossilfuel-based power plants.North America ... boilers market., The global power rental market is ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 A Massachusetts ... to the cancer risks associated with power morcellators ( ... their story to federal regulators, as they presented poignant ... Food & Drug Administration (FDA) advisory panel meeting convened ... According to the Rochester Democrat and Chronicle, Dr. Hooman ...
(Date:7/13/2014)... July 13, 2014 The federal court ... ) filed against Johnson & Johnson’s Ethicon, Inc. ... which is expected to get underway next month. According ... U.S. District Court, Southern District of West Virginia on ... on August 7, 2014 at 3:00 p.m. July selection ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 Fadhits.com is ... sexy prom dresses are extremely beautiful. Recently, the company ... dresses for 2014. What’s more, all these outfits ... percent off). , Additionally, the supplier is now ... with elegant Quinceanera dresses, it has many other designs ...
(Date:7/13/2014)... According to the Kidney Disease Solution book review recently updated ... what to do to eliminate the root cause of ... review that readers can easily learn what foods to avoid ... Vkool also informs in its Kidney Disease Solution review that ... naturally. The book consists of a collection of natural remedies ...
Breaking Medicine News(10 mins):Health News:North America Advanced Boilers Market is Expected to Reach $518.7billion by 2019 - New Report by MicroMarket Monitor 2Health News:North America Advanced Boilers Market is Expected to Reach $518.7billion by 2019 - New Report by MicroMarket Monitor 3Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 2Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 3Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 4Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 2Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 3Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 4Health News:Fadhits.com Announces a Special Offer on Elegant Quinceanera Dresses 2Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 2Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 3
(Date:7/11/2014)... normal circumstances, astrocytes participate in normal physiological ... exhibit therapeutic and repairing effects on brain ... found that nerve cells differentiated from adipose-derived ... viability, which produces influences on subsequent studies ... Hospital, Hebei United University, China demonstrated that ...
(Date:7/11/2014)... Research and Markets has announced ... - Industry Analysis Size Share Growth Trends and Forecast ... http://photos.prnewswire.com/prnh/20130307/600769 The rising ... need for high level security in both private and ... as username and passwords, tokens etc. are vulnerable to ...
(Date:7/11/2014)... brains of all vertebrates, information is transmitted through ... chemical signal to be passed from one brain ... most abundant type of synapse, can be either ... learning, memory, perception and cognition, and the balance ... function. For instance, every time we learn ...
Breaking Biology News(10 mins):International Biometrics Technology Market - Industry Analysis Size Share Growth Trends and Forecast to 2019 2Blame it on the astrocytes 2
Other Contents